Evidence map›Paper›PMID 41334637›Full record

SynthesisMovement disorders clinical practice2026

Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome.

Tamara Pringsheim, Catherine Deans, Saar Anis, Poonam Bhatia, Kevin Black, Yildiz Degirmenci, Donald Gilbert, Andreas Hartmann, Mariam Hull, Irene Malaty and 12 more

Abstract readSystematic Review
In one paragraph

Synthesis in Movement disorders clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Tourette syndrome.Nature reviews. Disease primers · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Tamara PringsheimDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-8229-8431
Catherine DeansDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Saar AnisCenter for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Poonam BhatiaUniversity of Arizona and Phoenix Children's Hospital, Phoenix, Arizona, USA.
Kevin BlackDepartments of Psychiatry, Neurology, Radiology and Neuroscience, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-6921-9567
Yildiz DegirmenciFaculty of Medicine, Department of Neurology, Istanbul Turkey.2 Istanbul Medicana Zincirlikuyu Hospital, Neurology Clinic, Parkinson' s Disease and Movement Disorders Unit, Istanbul Health and Technology University, Istanbul, Turkey.
Donald GilbertDivision of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID https://orcid.org/0000-0002-9245-6878
Andreas HartmannCentre de Référence National Maladie Rare "Syndrome Gilles de la Tourette," Hôpital de la Pitié-Salpêtrière, Paris, France.
Mariam HullTexas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-7340-1660
Irene MalatyDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0001-6914-9223
Davide MartinoDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-2217-0487
Alex Medina EscobarMoncton Interdisciplinary Neurodegenerative Diseases (MIND) Clinic, Horizon Health Network, New Brunswick, Canada.ORCID https://orcid.org/0000-0001-8640-3967
Pablo MirUnidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain, and Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain.ORCID https://orcid.org/0000-0003-1656-302X
Christelle NillesDepartment of Neurology, Hôpital Fondation Rothschild, Paris, France.ORCID https://orcid.org/0000-0001-5834-3266
Marianna SarchiotoKing's College Hospital NHS Foundation Trust, London, UK.
Jibrin Sammani UsmanDepartment of Physiotherapy, Faculty of Allied Health Sciences, Bayero University, Kano, Nigeria, and Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, SAR, China.
Harini SarvaDepartment of Neurology, Weill Cornell Medicine, Parkinson's and Movement Disorders Institute, New York, NY, USA.
Katarzyna SmilowksaDepartment of Neurology, 5th Regional Hospital, Sosnowiec, Poland.ORCID https://orcid.org/0000-0001-9167-1624
Natalia SzejkoDepartment of Bioethics, Medical University of Warsaw, Warsaw, Poland.
Kinga TomczakTic Disorders and Tourette Syndrome Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Daniel van WamelenDepartment of Neuroimaging, Institute for Psychiatry, Psychology & Neuroscience, King's College London, London, UK, and King's College Hospital NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0003-0921-5158
Yulia WorbeDepartment of Clinical Neurophysiology, Sorbonne University - Saint Antoine & Pitié-Salpetriere Hospital, Paris, France.

Funding

International Parkinson and Movement Disorders SocietyTourette OCD Alberta Network
6 · The paper itself

Abstract

backgroundThere is widespread interest in complementary and integrative medicine (CIM) among people with Tourette's syndrome (TS).

objectiveTo perform a systematic review of evidence on the use of CIM to reduce tics and improve tic-related quality of life.

methodsWe included clinical studies of CIM in children, adolescents and adults with TS and chronic tic disorders, and assessed the change in tic severity and/or tic-related quality of life using validated scales. Risk of bias of randomized controlled trials was assessed using the risk of bias tool of the American Academy of Neurology, which classifies studies into Class I, II, III or IV based on quality criteria.

results49 clinical studies and three systematic reviews were included. Most studies were rated Class IV and therefore at high risk of bias. Class I studies demonstrated efficacy of functional MRI neurofeedback, 5-Ling granule, Jingxin Zhidong formula, and Ningdong granule in reducing tic severity. Class II studies suggest efficacy of mindfulness-based intervention for tics, acupuncture combined with atlantoaxial joint bone setting therapy, and art therapy. Systematic reviews summarizing the Chinese literature on acupuncture, acupuncture with herbal medicine and massage therapy suggest greater reduction in tics compared to conventional treatments but there is low confidence in the evidence due to poor methodological quality of included studies.

conclusionsEvidence to support the use of complementary and integrative medicine for TS is limited in methodological quality and widespread applicability. These limitations prohibit evidence-based recommendations for general use among individuals with TS.

Indexed as

Complementary TherapiesIntegrative MedicineTourette SyndromeAdolescentChildHumansQuality of Life

Identifiers

PMID41334637
PMCPMC13172775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.